Vontobel Holding

Vontobel Holding’s BioCryst Pharmaceuticals BCRX Stock Holding History

Vontobel Holding’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$257K	Buy	+27,000	New	+$210K	﹤0.01%	1040
2021 Q4	–	Sell	-43,800	Closed	-$629K	–	1064
2021 Q3	$629K	Sell	43,800 -7,000	-14%	-$110K	0.01%	725
2021 Q2	$803K	Buy	50,800 +15,000	+42%	+$204K	0.01%	646
2021 Q1	$364K	Hold	35,800	–	–	﹤0.01%	743
2020 Q4	$267K	Buy	+35,800	New	+$185K	﹤0.01%	828

Other funds holding BCRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return